Heart-kidney transplant versus heart transplant in the obese: a propensity-matched analysis

Noah Weingarten1, Amit Iyengar1, David Alan Herbst1

  • 1Division of Cardiovascular Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Simultaneous heart-kidney transplants (HKT) show improved long-term survival compared to isolated heart transplants (IHT) in obese patients with advanced kidney disease. HKT is a preferred treatment option, reducing mortality risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Transplantation Medicine

Background:

  • Obesity presents unique challenges in organ transplantation decisions.
  • Advanced kidney disease complicates isolated heart transplant (IHT) outcomes.
  • Limited data guide simultaneous heart-kidney transplant (HKT) versus IHT in obese patients.

Purpose of the Study:

  • To compare mortality rates between HKT and IHT in obese patients with non-dialysis-dependent kidney disease.
  • To evaluate the long-term survival benefits of HKT versus IHT in this specific patient population.

Main Methods:

  • Retrospective analysis of adult heart transplant recipients (2000-2022) from the United Network for Organ Sharing.
  • Inclusion criteria: obesity, estimated glomerular filtration rate <45 mL/min/1.73 m², no pretransplant dialysis.
  • Propensity-matched analysis comparing HKT and IHT groups using survival assessments and Cox regression.

Main Results:

  • HKT recipients exhibited higher baseline creatinine and ICU disposition rates than IHT recipients.
  • Propensity matching created comparable HKT (n=239) and IHT (n=239) cohorts.
  • HKT demonstrated significantly higher 5- and 10-year survival rates in both unmatched and matched analyses.
  • HKT was associated with a reduced risk of 10-year mortality (HR 0.585, P=0.002).

Conclusions:

  • Simultaneous heart-kidney transplantation (HKT) is associated with decreased long-term mortality in obese patients with non-dialysis-dependent kidney disease.
  • HKT should be strongly considered as a preferred treatment strategy over isolated heart transplantation (IHT) for eligible patients.
  • This study provides critical evidence supporting HKT for improved survival outcomes in this complex patient group.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
34
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
51
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
460